Sun Pharma announced a regulatory clearance for one of its speciality products, supporting its strategy to shift towards higher-margin drugs.
Key details reported: Clearance received for a speciality product; Aligns with the company’s speciality push; Commercial timeline to follow.
Why it matters: Speciality approvals are key to Sun Pharma’s margin-expansion story.
This brief was prepared from publicly available information and attributed sources. The original source is linked above.